ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR
2.5700
16-5月-24 14:39:42
15 分の遅延
株式
-0.0896
-3.37%
本日の幅
2.3200 - 2.6724
ISIN
N/A
ソース
NASDAQ
-
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
29 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
07 3 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27 2 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
09 2 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 11:00:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at Investor and Scientific Conferences in September
07 9 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
31 8 2023 06:32:21 提供 Nasdaq GlobeNewswire
-
04 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Adagene Announces Updates to its Board of Directors
28 4 2023 06:00:11 提供 Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
28 3 2023 15:30:06 提供 Nasdaq GlobeNewswire
-
14 3 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Professor Aurélien Marabelle to Scientific and Strategic Advisory Board
05 3 2023 18:39:30 提供 Nasdaq GlobeNewswire
-
Adagene to Present at the Biotech Showcase™ 2023 in San Francisco on January 9
05 1 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
16 12 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Cuong Do to Board of Directors and Audit Committee
21 11 2022 15:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >